Search - tctmd.com

Displaying 521 - 540 of 595

Sort: Relevancy | Date

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

News Daily News

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Caitlin E. Cox

December 16, 2012

News Daily News

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

Jason Kahn

December 13, 2012

News Daily News

El Genérico Italiano Clopidogrel es Peor que la Marca Comercial en la Supresión Plaquetaria

Jason Kahn

December 13, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

July 12, 2012

News Daily News

Meta Análisis: Ajustar el Tratamiento según la Función Plaquetaria Mejora los Resultados

July 12, 2012

Presentation

Efficacy and Safety of Intensified Antiplatelet Therapy Based on Reactivity Testing After PCI

Presenter: D?niel Aradi

July 11, 2012

News Daily News

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Yael L. Maxwell

June 20, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

L.A. McKeown

May 23, 2012

News Daily News

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

L.A. McKeown

May 23, 2012

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

Presentation Fellows 2012

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

Presenter: Deepak Bhatt

April 22, 2012

News Daily News

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Caitlin E. Cox

April 12, 2012

Advertisement

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

El Genérico Italiano Clopidogrel es Peor que la Marca Comercial en la Supresión Plaquetaria

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

Meta Análisis: Ajustar el Tratamiento según la Función Plaquetaria Mejora los Resultados

Efficacy and Safety of Intensified Antiplatelet Therapy Based on Reactivity Testing After PCI

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content